JOHNSON & JOHNSON is 164.3x more valuable than Organon & Co. by market capitalization ($579.83 B vs $3.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OGN | JNJ |
|---|---|---|
| Market cap | $3.53 B | $579.83 B |
| US-listed rank | #1699 | #20 |
| Revenue (latest FY) | $6.22B | $94.19B |
| Net income (latest FY) | $187.00M | $26.80B |
| Net margin | 3.0% | 28.5% |
| P/E (trailing FY) | 18.9 | 21.6 |
| SEC filings | 433 | 984 |
JOHNSON & JOHNSON is 164.3x more valuable than Organon & Co. by market capitalization ($579.83 B vs $3.53 B).
In their latest fiscal years, Organon & Co. reported $6.22B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Organon & Co. and JOHNSON & JOHNSON, or browse the full rankings.